Blog

Learn more about Pierian by browsing our resources below!

    Our Latest Posts

    Filter by Topic
    1 min
    Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity
    Life gets better when we enter our "golden years" and retire, doesn’t
    PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR
    The Moffitt Morsani Molecular Laboratory, located within the Moffitt
    1 min
    PierianDx Showcases Germline Features in CGW at ACMG 2018
    PierianDx will be highlighting germline features of its genomics
    3 min
    CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients
    When CMS initiated a national coverage analysis for NGS-based testing
    5 min
    Precision Medicine in Canada
    We are excited to attend the upcoming Precision Oncology Experimental
    1 min
    PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada
    On April 5 and 6 oncology leaders will convene in Calgary, Alberta to
    Saving Infants with Genetic Testing
    Genetic diseases are the leading cause of death for infants in North
    PierianDx Customer Dartmouth-Hitchcock Medical Center Illustrates ALK-Rearranged Lung Cancer Patient Case in CAP Today Article
    Laura J. Tafe, MD, associate professor of pathology and laboratory
    1 min
    Precision Medicine to Improve Patient Safety
    While healthcare continues to improve, advances in technologies and
    2 min
    HIMSS18 Round-up: Why the Time for Precision Medicine is Now
    by Brad Herrick, PierianDx Like most people who have been going to
    1 min
    PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine
    PierianDx, the leading genomics technology company that enables